FP532THE PROGNOSTIC VALUE OF NEPHRO-CARDIAC BIOMARKERS IN HEMODIALYSIS PATIENTS - THE RANDOMIZED-CONTROLLED MIRENDA TRIAL. (18th May 2018) - Hauser, T